Validation of Diagnostic Usefulness of the Random Urine Na/K Ratio for Replacement of 24hr Urine Na Excretion in Cirrhotic Patients With Ascites (urine Na/K)

Jang Byoung Kuk

Status: Completed

Conditions: Liver Cirrhosis; Ascites

Study type: Observational

Funder types: Other

Identifiers

NCT03263598

random Urine Na/K

Details and patient eligibility

About

The low sodium intake is important for ascites control in liver cirrhosis patients. Therefore, World Health Organization (WHO) recommends reduction of sodium (Na) to 2g/day for adults. The 24-hour urine Na excretion has been regarded as a standard method to estimate the amount of daily dietary sodium intake. However, it is too inconvenient to apply to patients or the general population in practice. For this reason, it has been suggested that a spot urine Na/potassium (K) ratio could be replaced with the 24-hour urine Na excretion. However, the evidence is not sufficient for that. The investigators will evaluate the usefulness of spot urine Na/K ratio to estimate the dietary sodium intake. The investigators will also verify several formulas of estimating the 24-hour Na excretion with spot urine Na, K, Creatinine (Cr).

Full description

● Detailed Description:

1. Measurements: they should be performed for 2 days (the urine collected within 24 hrs)

   • 24-hour urine Na, K and Creatinine (patients were instructed to collect all subsequent urine voids over the next 24-hour period including the first void of the following day.)
   • Spot urine Na, K, Creatinine with the same urine sample in some containers provided to patients. (every urination)

2. Calculation

   • Na/K Ratio with spot urine Na, K
   • Estimating 24-hour urine Na with spot urine Na, K, Cr by using some formulas.

Enrollment: 195 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Liver cirrhotic patients with ascites diagnosed by imaging study, biopsy or clinically, regardless of taking diuretics.

Exclusion criteria

• Uncontrolled sepsis or systemic infection.
• Serum Creatinine >1.5 mg/dL.
• Patients who are being treated for cancers except hepatocellular carcinoma.
• Patients who refuse the examine or are not cooperative.